L J ESTATES LIMITED
Company number 13971082 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
L J ESTATES LIMITED - Analysis Report
Company Number: 13971082
Analysis Date: 2025-07-29 18:16 UTC
Financial Health Assessment Report for L J ESTATES LIMITED
1. Financial Health Score: C
Explanation:
L J ESTATES LIMITED shows a positive net asset position and an improving balance sheet from inception in 2022 through the latest accounts in 2024. However, the overall financial scale and resources remain modest, typical of a micro-entity in its early stage. The company is solvent with healthy working capital but has limited financial buffer and no employees, indicating a nascent stage of operational development. The grade reflects stable but very early-stage financial health with room for growth and resilience improvement.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Current Assets | 6,917 | Indicates available short-term resources such as cash or receivables; increased from £100 in 2023 reflecting some growth in liquidity. |
| Current Liabilities | 4,141 | Short-term debts to be settled within a year; presence requires monitoring cash flow to ensure timely payments. |
| Net Current Assets | 2,776 | Positive working capital signifies the company can cover near-term obligations without distress—a healthy "cash flow pulse." |
| Shareholders’ Funds | 2,776 | Reflects net worth; an increase from £100 in 2023 shows capital injection or retained earnings buildup—positive equity health. |
| Employees | Nil | No employees indicate minimal operational scale; typical for a micro-entity but could impact growth potential. |
| Audit Status | Exempt | Micro-entity exemption applies; while cost-saving, it limits external assurance on financial accuracy. |
3. Diagnosis: Financial Condition Insights
Solvency and Liquidity: The company maintains positive net current assets (working capital), a fundamental indicator of liquidity health. This suggests no immediate risk of insolvency or cash flow strain, akin to a patient with stable vital signs.
Growth Trajectory: From £100 net assets in 2023 to £2,776 in 2024, the company shows early-stage capital growth. This is a positive symptom of capital infusion or operational progress.
Operational Scale: Absence of employees and minimal asset base suggest the company is in its infancy or is operating a very lean model. This limits operational capacity but keeps overheads low.
Risk Factors: The small scale and limited financial buffer mean the company is vulnerable to unexpected expenses or market shocks, similar to a patient with a mild but manageable condition requiring careful monitoring.
Governance and Transparency: Directors are identified and active; no disqualifications or adverse records noted, indicating clean governance "history."
4. Recommendations: Steps to Improve Financial Wellness
Enhance Cash Reserves: Build a stronger cash buffer to improve resilience against unexpected costs or downturns—similar to building immunity strength.
Develop Revenue Streams: If not already initiated, focus on increasing business activities to grow turnover and move beyond micro-entity scale. This could involve investing in marketing or expanding service offerings.
Consider Hiring or Outsourcing: Adding operational capacity through staff or third parties can foster growth, though it requires balancing increased expenses.
Maintain Timely Filings: Continue compliance with Companies House filing deadlines to avoid penalties and maintain good standing.
Review Financial Controls: Even as a micro-entity, implement basic financial controls and budgets to monitor cash inflows and outflows closely.
Plan for Audit Readiness: As the company grows, prepare for the transition to a full audit which brings external validation and investor confidence.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.